Elgebaly, S.A.; Van Buren, C.; Todd, R.; Poston, R.; Arafa, R.K.; El-Khazragy, N.; Kreutzer, D.; Rabie, M.A.; Mohamed, A.F.; Ahmed, L.A.;
et al. Cyclocreatine Phosphate: A Novel Bioenergetic/Anti-Inflammatory Drug That Resuscitates Poorly Functioning Hearts and Protects against Development of Heart Failure. Pharmaceuticals 2023, 16, 453.
https://doi.org/10.3390/ph16030453
AMA Style
Elgebaly SA, Van Buren C, Todd R, Poston R, Arafa RK, El-Khazragy N, Kreutzer D, Rabie MA, Mohamed AF, Ahmed LA,
et al. Cyclocreatine Phosphate: A Novel Bioenergetic/Anti-Inflammatory Drug That Resuscitates Poorly Functioning Hearts and Protects against Development of Heart Failure. Pharmaceuticals. 2023; 16(3):453.
https://doi.org/10.3390/ph16030453
Chicago/Turabian Style
Elgebaly, Salwa A., Charles Van Buren, Robert Todd, Robert Poston, Reem K. Arafa, Nashwa El-Khazragy, Donald Kreutzer, Mostafa A. Rabie, Ahmed F. Mohamed, Lamiaa A. Ahmed,
and et al. 2023. "Cyclocreatine Phosphate: A Novel Bioenergetic/Anti-Inflammatory Drug That Resuscitates Poorly Functioning Hearts and Protects against Development of Heart Failure" Pharmaceuticals 16, no. 3: 453.
https://doi.org/10.3390/ph16030453
APA Style
Elgebaly, S. A., Van Buren, C., Todd, R., Poston, R., Arafa, R. K., El-Khazragy, N., Kreutzer, D., Rabie, M. A., Mohamed, A. F., Ahmed, L. A., & El Sayed, N. S.
(2023). Cyclocreatine Phosphate: A Novel Bioenergetic/Anti-Inflammatory Drug That Resuscitates Poorly Functioning Hearts and Protects against Development of Heart Failure. Pharmaceuticals, 16(3), 453.
https://doi.org/10.3390/ph16030453